07:00 , Apr 14, 2014 |  BC Week In Review  |  Financial News

Newron completes private placement

Newron Pharmaceuticals S.p.A. (SIX:NWRN), Bresso, Italy   Business: Neurology   Date completed: 4/7/14   Type: Private placement   Raised: CHF18.6 million ($20.9 million)   Shares: 1.2 million   Price: CHF15.75   Shares after offering: 13...
08:00 , Dec 3, 2012 |  BC Week In Review  |  Company News

BB Biotech AG deal

Swiss bank Vontobel Group withdrew an offer to take Swiss biotech fund BB Biotech private. According to the bank, new Swiss tax provisions on public exchange offers that took effect in October made the deal...
01:31 , Nov 21, 2012 |  BC Extra  |  Financial News

Vontobel withdraws offer for BB Biotech

Swiss bank Vontobel Group withdrew an offer to take Swiss biotech fund BB Biotech AG (SIX:BION; Xetra: BBZA) private. According to the bank, new Swiss tax provisions on public exchange offers that took effect in...
07:00 , Jul 16, 2012 |  BC Week In Review  |  Company News

BB Biotech AG deal

Swiss biotech fund BB Biotech rejected an offer from Swiss bank Vontobel Group to take it private. Vontobel said the offer is a 31.7% premium to the CHF81.95 BB Biotech share price on July 12,...
00:05 , Jul 14, 2012 |  BC Extra  |  Top Story

BB Biotech declines offer to go private

Swiss biotech fund BB Biotech AG (SIX:BION; Xetra:BBZA) rejected an offer from Swiss bank Vontobel Group to take it private. Vontobel said the offer is a 31.7% premium to the CHF81.95 BB Biotech share price...
07:00 , Sep 14, 2009 |  BC Week In Review  |  Company News

Arpida, Evolva deal

Evolva plans to raise funds in an equity financing and subsequently reverse-merge with Arpida in a stock deal. The companies said Evolva will conduct an equity financing prior to the deal's completion and that investors...
00:07 , Sep 12, 2009 |  BC Extra  |  Company News

Arpida, Evolva to reverse-merge

Evolva S.A. (Allschwil, Switzerland) said on Thursday that it will reverse-merge with Arpida Ltd. (SIX:ARPN) in a stock deal. The companies said Evolva will conduct an equity financing prior to the deal's completion and that...
02:07 , Nov 7, 2008 |  BC Extra  |  Financial News

Santhera raises $13.7 million

Santhera (SWX:SANN) raised CHF15.9 million ($13.7 million) in a private placement of 370,000 shares at CHF43. The deal price is a 7% discount to Santhera's close of CHF46 on Wednesday, before the deal was announced....
07:00 , May 28, 2007 |  BioCentury  |  Finance

Adding up Addex

Buysiders were clearly split on the pricing of the Addex IPO on the SWX Swiss Exchange last week. Despite being more than four times over-subscribed, the stock - which priced last Monday at CHF73 a...
01:27 , May 22, 2007 |  BC Extra  |  Financial News

Addex prices IPO

Neurology and gastrointestinal company Addex (SWX:ADXN) raised CHF137 million ($111.6 million) through the sale of 1.9 million shares at CHF73 in an IPO on the SWX Swiss Exchange and a private placement outside Switzerland. The...